COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration
Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.
Next-generation sequencing (NGS)-based test reportedly diagnoses the presence of COVID-19 and also provides information about viral variants.
The clinical performance of this innovative device was studied in hospital and school settings.
In a new first, molecular testing for COVID-19 can now be performed at home without a prescription, changing the COVID-19 testing market.
This alert identifies two issues and issues three recommendations.
Centers for Medicare and Medicaid Services (CMS) makes at least eight key points about commercial payer coverage related to COVID-19 testing and vaccination.
While T-cell immunity is still a very active field of COVID-19 study, this new test now allows clinicians to offer T-cell COVID-19 testing for their patients.
Next-generation sequencing (NGS)-based test reportedly diagnoses the presence of COVID-19 and also provides information about viral variants.
The clinical performance of this innovative device was studied in hospital and school settings.
In a new first, molecular testing for COVID-19 can now be performed at home without a prescription, changing the COVID-19 testing market.
This alert identifies two issues and issues three recommendations.
Centers for Medicare and Medicaid Services (CMS) makes at least eight key points about commercial payer coverage related to COVID-19 testing and vaccination.
While T-cell immunity is still a very active field of COVID-19 study, this new test now allows clinicians to offer T-cell COVID-19 testing for their patients.
